GoingToMeet

Advancements in stem cell research and tissue engineering hold the promise of introducing a new trove of regenerative therapies to treat diseases and conditions by restoring or repairing genetic and cellular defects. Over the past decade alone billions of dollars of investment have poured into the sector, and with over 550 global companies developing or collaborating on regenerative products, the clinical development stakes are high. Understanding the current challenges and the technological advances is critical for successful transition from bench to clinic.

Arrowhead-Spectra’s 1st International Clinical Development Congress in Cell Therapies and Tissue Engineering is the forum to decipher the progress of clinical-phase candidates and technologies that have the potential to succeed in the highly competitive global marketplace. Based on presentations of case studies, trials, and proprietary data, the conference will be an unmissable event that focuses pioneering clinical development work.